Government Investigation Finds Flaws In the FDA鈥檚 Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
Health Industry
2,121 - 2,140 of 3,969 Results
-
-
Look-Up: Medicare’s Bonuses And Penalties For Nursing Homes Near You
The federal government is issuing bonuses and penalties to skilled nursing facilities based on how often their patients are readmitted to hospitals within a month of being discharged.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Sales Reps May Be Wearing Out Their Welcome In The Operating Room
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Reading The Tea Leaves In Blue Wave鈥檚 Wake
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN鈥檚 Jay Hancock about the latest 鈥淏ill of the Month.鈥
-
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS
Shereese Hickson鈥檚 doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.
By Jay Hancock -
One Twin’s Difficult Birth Puts A Project Designed To Reduce C-Sections To The Test
A woman had twins in a hospital south of Boston, and for doctors aiming to reduce cesarean sections, the second baby's tricky arrival tested the limits of teamwork.
-
Buyers Of Short-Term Health Plans: Wise Or Shortsighted?
Policyholders reason that their health is good 鈥 for now 鈥 and they don鈥檛 see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. 鈥淵ou basically have to be in perfect health,鈥 says one.
By Anna Gorman -
Playing On Fear And Fun, Hospitals Follow Pharma In Direct-To-Consumer Advertising
Hospitals are increasingly advertising medical services directly to patients to enhance their national brands. They think the image building improves their ability to negotiate with health plans and brings in wealthier patients.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
An Underused Strategy For Surge In STDs: Treat Patients鈥 Partners Without A Doctor Visit
For over a decade, federal health officials have recommended the practice, known as expedited partner therapy. It is allowed in most states, but many doctors don鈥檛 do it 鈥 either because of legal or ethical concerns, or because they are unaware of it.
By Anna Gorman -
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
By Liz Szabo -
Measure To Cap Dialysis Profits Pummeled After Record Spending By Industry
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
By Ana B. Ibarra and Anna Gorman -
Beyond The Buzz: What Do Americans Mean By ‘Medicare-For-All’?
KHN's news analysis on "Medicare-for-all" sparks a broader conversation.
-
Like Clockwork: How Daylight Saving Time Stumps Hospital Record-Keeping
One of the most popular electronic health records software systems used by hospitals, Epic Systems,聽can delete records or require cumbersome workarounds when clocks are set back for an hour, prompting many hospitals to opt for paper records for part of the night shift.
-
The Election鈥檚 Impact On Health Care: Some Bellwether Races To Watch
A number of health issues 鈥 from preexisting conditions to Medicaid expansion to changes to Medicare 鈥 could be at stake when voters head to the polls Tuesday.
By Julie Rovner -
Heart Drug Spotlights Troubling Trends In Drug Marketing
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
-
Billions In 鈥楺uestionable Payments鈥 Went To California鈥檚 Medicaid Insurers And Providers
The money was paid on behalf of more than 400,000 people who may have been ineligible for the public program, a state audit found. One had been dead for four years before payments stopped.
By Chad Terhune -
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won鈥檛 cover the skyrocketing cost.
By Liz Szabo -
Dialysis Giant DaVita Defends Itself In Court And At The Polls
Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company faces its biggest threat next month, when California voters weigh in on a ballot initiative that could force it to leave the state.